2022 annual financial data
Protagonist Therapeutics 2022 Operating margin
Protagonist Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -494.24%.
Operating income was -131,373,000 USD and net income was -123,413,000 USD.
Operating cash flow was -108,137,000 USD.
Get free Protagonist Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,581,000 USD
- Operating income
- -131,373,000 USD
- Net income
- -123,413,000 USD
- Operating cash flow
- -108,137,000 USD